Примери за използване на Granted a marketing authorisation на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The European Commission granted a marketing authorisation valid throughout the European Union, for Equilis Prequenza on 8 July 2005.
The European Commission granted a marketing authorisation valid throughout the EU for Binocrit to Sandoz GmbH on 28 August 2007.
The medicine was therefore granted a marketing authorisation on condition that the company provided additional data from the ANNOUNCE study
The European Commission granted a marketing authorisation valid throughout the EU for ZULVAC 8 Ovis on 15 January 2010.
The European Commission granted a marketing authorisation valid throughout the EU for Celvapan to Baxter AG on 04 March 2009.
The European Commission granted a marketing authorisation valid throughout the European Union,
The European Commission granted a marketing authorisation valid throughout the EU for Omnitrope to Sandoz GmbH on 12 April 2006.
The European Commission granted a marketing authorisation valid throughout the EU for Optaflu to Novartis Vaccines
The European Commission granted a marketing authorisation valid throughout the European Union, for Eryseng on 4 July 2014.
The European Commission granted a marketing authorisation valid throughout the European Union for Osigraft to Howmedica International S. de R.
The European Commission granted a marketing authorisation valid throughout the EU for BTVPUR AlSap 2-4 on 5 November 2010.
The European Commission granted a marketing authorisation valid throughout the European Union for Diacomit to Biocodex on 4 January 2007.
The European Commission granted a marketing authorisation valid throughout the European Union, for RESPIPORC FLU3 to IDT Biologika GmbH on 14/01/2010.
The European Commission granted a marketing authorisation valid throughout the European Union,
The European Commission granted a marketing authorisation valid throughout the EU for Siklos to Addmedica on 29 June 2007.
The European Commission granted a marketing authorisation valid throughout the European Union for Zulvac 1+8 Bovis on 08/03/2012.
The European Commission granted a marketing authorisation valid throughout the European Union for Fasturtec to sanofi-aventis on 23 February 2001.
The European Commission granted a marketing authorisation valid throughout the European Union, for Suvaxyn PCV on 24 July 2009.
The European Commission granted a marketing authorisation valid throughout the European Union for Helixate NexGen on 4 August 2000.
The European Commission granted a marketing authorisation valid throughout the European Union for Fortekor Plus on 8 September 2015.